China plans comprehensive reform of drug regulations

02/27/2013 | Regulatory Focus

China's State Food and Drug Administration has announced plans for wide-ranging changes in its drug regulatory process. The plan will foster research and development through a more favorable regulatory environment; update the national strategy for generic drugs; boost the quality of pharmaceutical clinical trials and how they are managed; and encourage the creation of more pediatric pharmaceuticals.

View Full Article in:

Regulatory Focus

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Finance Manager - ENT
Medtronic
Jacksonville, FL